TCOT
DGX icon

Trust Company of Toledo’s Quest Diagnostics DGX Stock Holding History

Trust Company of Toledo’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2K Buy
+48
New +$9.42K ﹤0.01% 693

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

Trust Company of Toledo's DGX Position: Q2 2026 in Review

Trust Company of Toledo opened a new position in Quest Diagnostics (DGX) in Q2 2026: 48 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #693 among its holdings.

503 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Trust Company of Toledo held 48 shares of Quest Diagnostics worth $10.2K as of Q2 2026.
  • Quest Diagnostics was a new Trust Company of Toledo position in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #693 holding.
  • 503 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.